2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Lymphoma
225
Lymphoma, Large B-Cell, Diffuse
160
Small Cell Lung Carcinoma
156
Precursor Cell Lymphoblastic Leukemia-Lymphoma
143
Lymphoma, Non-Hodgkin
139
Leukemia
135
Leukemia, Myeloid, Acute
117
Hodgkin Disease
106
Lung Neoplasms
99
Burkitt Lymphoma
99
Lymphoma, Follicular
85
Lymphoma, Mantle-Cell
76
Lymphoma, Large-Cell, Immunoblastic
68
Carcinoma, Non-Small-Cell Lung
61
Neuroblastoma
60
Leukemia, Lymphocytic, Chronic, B-Cell
56
Recurrence
53
Multiple Myeloma
52
Lymphoma, B-Cell, Marginal Zone
43
Congenital Abnormalities
43
Sarcoma
39
Central Nervous System Neoplasms
39
Myelodysplastic Syndromes
35
Brain Neoplasms
34
Ovarian Neoplasms
32
Leukemia, Myelomonocytic, Acute
32
Lymphoma, B-Cell
31
Leukemia, Monocytic, Acute
31
Leukemia, Erythroblastic, Acute
31
Testicular Neoplasms
30
Interventions
Cancer Vaccines
2
Adjuvants, Immunologic
2
veliparib
1
sargramostim
1
glutathione pegylated liposomal doxorubicin
1
etoposide phosphate
1
Vincristine
1
Trastuzumab
1
Tissue Banks
1
Sunitinib
1
Modafinil
1
Methotrexate
1
Leucovorin
1
Etoposide
1
Doxorubicin
1
Dexamethasone
1
Data Collection
1
Cytarabine
1
Cyclophosphamide
1
Bleomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Nervous System Neoplasms
×
Etoposide
×
Clear all
NCT05762419
2026-01-28
FUS Etoposide for DMG
Columbia University
Phase 1
Recruiting
10 enrolled